Nuveen Asset Management, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 234 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2024$24,588,469
-17.2%
932,441
-4.6%
0.01%
-22.2%
Q1 2024$29,692,931
+5.2%
977,706
-2.7%
0.01%0.0%
Q4 2023$28,215,310
+0.8%
1,004,461
-2.6%
0.01%
-10.0%
Q3 2023$27,988,369
-12.7%
1,031,259
-1.1%
0.01%
-9.1%
Q2 2023$32,044,974
+88263.4%
1,042,452
+3.6%
0.01%
-15.4%
Q1 2023$36,265
-9.7%
1,006,533
-1.0%
0.01%
-18.8%
Q4 2022$40,182
-99.9%
1,016,755
+2.7%
0.02%0.0%
Q3 2022$39,784,000
-3.5%
990,138
+1.0%
0.02%0.0%
Q2 2022$41,222,000
+15.3%
980,548
+6.9%
0.02%
+33.3%
Q1 2022$35,743,000
-1.5%
917,431
+0.7%
0.01%
+9.1%
Q4 2021$36,302,000
+1.7%
910,952
-7.8%
0.01%0.0%
Q3 2021$35,689,000
-27.1%
987,535
-17.4%
0.01%
-26.7%
Q2 2021$48,978,000
-6.3%
1,194,882
-0.3%
0.02%
-11.8%
Q1 2021$52,282,000
+157.7%
1,198,587
+195.7%
0.02%
+142.9%
Q4 2020$20,289,000
+84.1%
405,378
+54.7%
0.01%
+75.0%
Q3 2020$11,023,000261,9990.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$263,446,00059.92%
Memorial Sloan Kettering Cancer Center 1,128,255$43,957,00050.90%
Vantage Consulting Group Inc 2,727,854$106,277,00041.47%
Indie Asset Partners, LLC 756,874$29,488,00022.15%
Overbrook Management Corp 723,250$28,178,0006.25%
Brown University 621,759$24,224,0005.93%
Geo Capital Gestora de Recursos Ltd 200,692$8,527,0003.82%
Lagoda Investment Management, L.P. 141,560$5,515,0002.97%
Greytown Advisors Inc. 131,143$5,109,0002.47%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,025,610$78,918,0002.41%
View complete list of ROYALTY PHARMA PLC shareholders